162 related articles for article (PubMed ID: 32088782)
21. Clinical course of stage IV invasive mucinous adenocarcinoma of the lung.
Cha YJ; Kim HR; Lee HJ; Cho BC; Shim HS
Lung Cancer; 2016 Dec; 102():82-88. PubMed ID: 27987593
[TBL] [Abstract][Full Text] [Related]
22. Ground-Glass Opacity Is a Strong Prognosticator for Pathologic Stage IA Lung Adenocarcinoma.
Miyoshi T; Aokage K; Katsumata S; Tane K; Ishii G; Tsuboi M
Ann Thorac Surg; 2019 Jul; 108(1):249-255. PubMed ID: 30876742
[TBL] [Abstract][Full Text] [Related]
23. The importance of the lepidic component as a prognostic factor in stage I pulmonary adenocarcinoma.
Moon Y; Sung SW; Lee KY; Kim YK; Park JK
World J Surg Oncol; 2016 Feb; 14(1):37. PubMed ID: 26879575
[TBL] [Abstract][Full Text] [Related]
24. [Prognostic study of visceral pleural invasion by pulmonary adenocarcinoma with tumor size ≤3 cm].
Chen TY; Ma HW; Jin RR; Xu C; Hua HJ; Song GX; Zhang WM; Zhang ZH
Zhonghua Bing Li Xue Za Zhi; 2017 Aug; 46(8):553-558. PubMed ID: 28810296
[No Abstract] [Full Text] [Related]
25. Excellent prognosis of lepidic-predominant lung adenocarcinoma: low incidence of lymphatic vessel invasion as a key factor.
Araki K; Kidokoro Y; Hosoya K; Wakahara M; Matsuoka Y; Takagi Y; Haruki T; Miwa K; Taniguchi Y; Horie S; Nakamura H
Anticancer Res; 2014 Jun; 34(6):3153-6. PubMed ID: 24922687
[TBL] [Abstract][Full Text] [Related]
26. Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society.
Xu L; Tavora F; Battafarano R; Burke A
Am J Surg Pathol; 2012 Feb; 36(2):273-82. PubMed ID: 22198010
[TBL] [Abstract][Full Text] [Related]
27. Second predominant subtype predicts outcomes of intermediate-malignant invasive lung adenocarcinoma†.
Ito M; Miyata Y; Yoshiya T; Tsutani Y; Mimura T; Murakami S; Ito H; Nakayama H; Okada M
Eur J Cardiothorac Surg; 2017 Feb; 51(2):218-222. PubMed ID: 28186287
[TBL] [Abstract][Full Text] [Related]
28. Adenocarcinoma classification: patterns and prognosis.
Kuhn E; Morbini P; Cancellieri A; Damiani S; Cavazza A; Comin CE
Pathologica; 2018 Mar; 110(1):5-11. PubMed ID: 30259909
[TBL] [Abstract][Full Text] [Related]
29. A Proposal for Definition of Minimally Invasive Adenocarcinoma of the Lung Regardless of Tumor Size.
Suzuki S; Sakurai H; Masai K; Asakura K; Nakagawa K; Motoi N; Watanabe SI
Ann Thorac Surg; 2017 Sep; 104(3):1027-1032. PubMed ID: 28551046
[TBL] [Abstract][Full Text] [Related]
30. Validation of stage groupings in the eighth edition of the tumor node metastasis classification for lung adenocarcinoma.
Yu W; Zhao Q; Xia C; Dong M; Liu J; Li X; Zhao H; Chen G; Liu H; Chen J
Thorac Cancer; 2019 Mar; 10(3):483-491. PubMed ID: 30648815
[TBL] [Abstract][Full Text] [Related]
31. Lepidic predominant adenocarcinoma and invasive mucinous adenocarcinoma of the lung exhibit specific mucin expression in relation with oncogenic drivers.
Duruisseaux M; Antoine M; Rabbe N; Rodenas A; Mc Leer-Florin A; Lacave R; Poulot V; Duchêne B; Van Seuningen I; Cadranel J; Wislez M
Lung Cancer; 2017 Jul; 109():92-100. PubMed ID: 28577958
[TBL] [Abstract][Full Text] [Related]
32. What CT characteristics of lepidic predominant pattern lung adenocarcinomas correlate with invasiveness on pathology?
Aherne EA; Plodkowski AJ; Montecalvo J; Hayan S; Zheng J; Capanu M; Adusumilli PS; Travis WD; Ginsberg MS
Lung Cancer; 2018 Apr; 118():83-89. PubMed ID: 29572008
[TBL] [Abstract][Full Text] [Related]
33. Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma.
Sasada S; Miyata Y; Mimae T; Tsutani Y; Mimura T; Okada M
Clin Lung Cancer; 2016 Sep; 17(5):433-440.e1. PubMed ID: 26725850
[TBL] [Abstract][Full Text] [Related]
34. Clinical and Pathological Staging Validation in the Eighth Edition of the TNM Classification for Lung Cancer: Correlation between Solid Size on Thin-Section Computed Tomography and Invasive Size in Pathological Findings in the New T Classification.
Aokage K; Miyoshi T; Ishii G; Kusumoto M; Nomura S; Katsumata S; Sekihara K; Hishida T; Tsuboi M
J Thorac Oncol; 2017 Sep; 12(9):1403-1412. PubMed ID: 28627462
[TBL] [Abstract][Full Text] [Related]
35. Spread through air spaces (STAS) in invasive mucinous adenocarcinoma of the lung: Incidence, prognostic impact, and prediction based on clinicoradiologic factors.
Lee MA; Kang J; Lee HY; Kim W; Shon I; Hwang NY; Kim HK; Choi YS; Kim J; Zo JI; Shim YM
Thorac Cancer; 2020 Nov; 11(11):3145-3154. PubMed ID: 32975379
[TBL] [Abstract][Full Text] [Related]
36. Invasive mucinous adenocarcinoma with lepidic-predominant pattern coexisted with tuberculosis: a case report.
Xu X; Guo Y; Li Q; Yang L; Kang J
Front Med; 2018 Jun; 12(3):330-333. PubMed ID: 28687977
[TBL] [Abstract][Full Text] [Related]
37. High-Risk Factors for Recurrence of Stage I Lung Adenocarcinoma: Follow-up Data From JCOG0201.
Tsutani Y; Suzuki K; Koike T; Wakabayashi M; Mizutani T; Aokage K; Saji H; Nakagawa K; Zenke Y; Takamochi K; Ito H; Aoki T; Okami J; Yoshioka H; Okada M; Watanabe SI;
Ann Thorac Surg; 2019 Nov; 108(5):1484-1490. PubMed ID: 31336067
[TBL] [Abstract][Full Text] [Related]
38. Proportion of goblet cell is associated with malignant potential in invasive mucinous adenocarcinoma of the lung.
Oki T; Aokage K; Ueda T; Sugano M; Tane K; Miyoshi T; Kojima M; Fujii S; Kuwata T; Ochiai A; Funai K; Tsuboi M; Ishii G
Pathol Int; 2019 Sep; 69(9):526-535. PubMed ID: 31559671
[TBL] [Abstract][Full Text] [Related]
39. Invasive, mixed-type intraductal papillary mucinous neoplasm: superior prognosis compared to invasive main-duct intraductal papillary mucinous neoplasm.
Ceppa EP; Roch AM; Cioffi JL; Sharma N; Easler JJ; DeWitt JM; House MG; Zyromski NJ; Nakeeb A; Schmidt CM
Surgery; 2015 Oct; 158(4):937-44; discussion 944-5. PubMed ID: 26173683
[TBL] [Abstract][Full Text] [Related]
40. Size of Non-lepidic Invasive Pattern Predicts Recurrence in Pulmonary Mucinous Adenocarcinoma: Morphologic Analysis of 188 Resected Cases with Reappraisal of Invasion Criteria.
Hwang S; Han J; Choi M; Ahn MJ; Choi YS
J Pathol Transl Med; 2017 Jan; 51(1):56-68. PubMed ID: 27744658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
